G Teuber

2.4k total citations
108 papers, 1.7k citations indexed

About

G Teuber is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, G Teuber has authored 108 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Hepatology, 77 papers in Epidemiology and 22 papers in Rheumatology. Recurrent topics in G Teuber's work include Hepatitis C virus research (92 papers), Liver Disease Diagnosis and Treatment (50 papers) and Hepatitis B Virus Studies (49 papers). G Teuber is often cited by papers focused on Hepatitis C virus research (92 papers), Liver Disease Diagnosis and Treatment (50 papers) and Hepatitis B Virus Studies (49 papers). G Teuber collaborates with scholars based in Germany, United States and Switzerland. G Teuber's co-authors include Stefan Zeuzem, Thomas Berg, Jung-Hun Lee, Michael Wagner, Christoph Sarrazin, Christoph F. Dietrich, W. Kurt Roth, Stefan Zeuzem, Jürgen M. Schmidt and Robert Kokka and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

G Teuber

101 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G Teuber Germany	25	1.5k	1.3k	204	171	103	108	1.7k
Wolf Peter Hofmann Germany	24	1.8k 1.2×	1.7k 1.3×	268 1.3×	107 0.6×	129 1.3×	72	2.3k
Ming‐Yuh Hsieh Taiwan	25	1.9k 1.3×	1.8k 1.4×	145 0.7×	206 1.2×	88 0.9×	72	2.2k
Leif Bengtsson United States	13	1.1k 0.8×	965 0.7×	280 1.4×	167 1.0×	45 0.4×	31	1.4k
Alexandra L. Gibas United States	9	1.9k 1.3×	1.9k 1.4×	194 1.0×	350 2.0×	87 0.8×	12	2.3k
Marie–Pierre Ripault France	20	2.2k 1.5×	2.2k 1.7×	131 0.6×	147 0.9×	91 0.9×	34	2.5k
Emilia Hadziyannis Greece	24	1.2k 0.8×	1.4k 1.1×	203 1.0×	123 0.7×	149 1.4×	76	1.8k
F Roudot-Thoraval France	15	764 0.5×	766 0.6×	97 0.5×	207 1.2×	58 0.6×	34	1.2k
M Duffaut France	16	971 0.6×	827 0.6×	108 0.5×	158 0.9×	97 0.9×	49	1.2k
J. Moussalli France	24	2.3k 1.5×	2.3k 1.8×	132 0.6×	126 0.7×	105 1.0×	56	2.7k
Pier Luigi Calvo Italy	19	892 0.6×	790 0.6×	79 0.4×	116 0.7×	243 2.4×	72	1.3k

Countries citing papers authored by G Teuber

Since Specialization

Citations

This map shows the geographic impact of G Teuber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Teuber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Teuber more than expected).

Fields of papers citing papers by G Teuber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Teuber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Teuber. The network helps show where G Teuber may publish in the future.

Co-authorship network of co-authors of G Teuber

This figure shows the co-authorship network connecting the top 25 collaborators of G Teuber. A scholar is included among the top collaborators of G Teuber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Teuber. G Teuber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rossol, S., Christian Krauth, Peter Buggisch, et al.. (2022). Real‐world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R). Zeitschrift für Gastroenterologie. 61(5). 489–503. 3 indexed citations

Stoehr, Albrecht, Hartwig Klinker, G Teuber, et al.. (2020). Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease - Data from the German Hepatitis C-Registry (DHC-R). Zeitschrift für Gastroenterologie. 2 indexed citations

Heidrich, Benjamin, Steffen B. Wiegand, Peter Buggisch, et al.. (2014). Treatment of Naïve Patients with Chronic Hepatitis C Genotypes 2 and 3 with Pegylated Interferon Alpha and Ribavirin in a Real World Setting: Relevance for the New Era of DAA. PLoS ONE. 9(10). e108751–e108751. 13 indexed citations

Stahmeyer, Jona T., S. Rossol, Ahmed Abdelfattah, et al.. (2013). Epidemiology, Treatment Outcomes and Costs of Treating Hepatitis C in Routine Care – Results from a Large Multicenter Trial. Value in Health. 16(7). A341–A342. 2 indexed citations

Kraus, Michael R., Arne Schäfer, G Teuber, et al.. (2013). Improvement of Neurocognitive Function in Responders to an Antiviral Therapy for Chronic Hepatitis C. Hepatology. 58(2). 497–504. 38 indexed citations

Boeker, Klaus, Christoph Eisenbach, Bernd Moeller, et al.. (2013). 871 REAL-WORLD EFFICACY AND SAFETY OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON alfa-2a AND RIBAVIRIN: INTERIM ANALYSIS FROM THE GERMAN NON-INTERVENTIONAL PAN STUDY. Journal of Hepatology. 58. S357–S358. 1 indexed citations

Sarrazin, Christoph, Susanne Schwendy, Bernd Möller, et al.. (2011). Improved Responses to Pegylated Interferon Alfa-2b and Ribavirin by Individualizing Treatment for 24–72 Weeks. Gastroenterology. 141(5). 1656–1664. 34 indexed citations

Stein, Jamal M., K. Winckler, & G Teuber. (2011). Komplikationen und metabolische Störungen nach bariatrischen Operationen aus gastroenterologischer Sicht. Der Gastroenterologe. 6(1). 33–39. 1 indexed citations

Jaeckel, Elmar, E Zehnter, C John, et al.. (2010). 266 CLINICAL MARKERS OF THE METABOLIC SYNDROME ARE ASSOCIATED WITH HCV GENOTYPE 1 INFECTION AND ARE STRONG NEGATIVE PREDICTORS OF EARLY VIROLOGICAL RESPONSE. Journal of Hepatology. 52. S112–S112. 2 indexed citations

10.

Berger, Annemarie, Tsanan Giroglou, Henry Ogbomo, et al.. (2009). Measurements of HCV neutralizing antibodies and of HCV-specific CD4+ and CD8+ cells using hepatitis C virus pseudo-particles (HCVpp). Journal of Clinical Virology. 46(1). 55–60. 4 indexed citations

11.

Teuber, G, Arne Schäfer, Kathrin Paul, et al.. (2008). Deterioration of health-related quality of life and fatigue in patients with chronic hepatitis C: Association with demographic factors, inflammatory activity, and degree of fibrosis. Journal of Hepatology. 49(6). 923–929. 44 indexed citations

12.

Jensen, Dorte Møller, Pietro Andreoné, Y. Benhamou, et al.. (2006). 583 Safety of peginterferon α-2a (40KD) (PEGASYS®) [PEG-IFNα-2a (40KD)] plus ribavirin (COPEGUS®) among pegylated interferon α-2b (12KD)/ribavirin non-responders: Interim analysis of the repeat study. Journal of Hepatology. 44. S216–S217. 1 indexed citations

13.

Berg, Thomas, V Weich, G Teuber, et al.. (2006). Individualisierte Therapiestrategie mit Peginterferon alfa–2b (PEG-IFNa) plus Ribavirin in Abhängigkeit von der frühen Viruskinetik bei Hepatitis C Virus (HCV) Typ 1-infizierten Patienten. Zeitschrift für Gastroenterologie. 44(1).

14.

Schneider, A, et al.. (2006). PATIENT AGE IS A STRONG INDEPENDENT PREDICTOR OF ¹³C‐AMINOPYRINE BREATH TEST RESULTS: A COMPARATIVE STUDY WITH HISTOLOGY, DUPLEX‐DOPPLER AND A LABORATORY INDEX IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION. Clinical and Experimental Pharmacology and Physiology. 33(4). 300–304. 16 indexed citations

15.

Diepolder, Helmut M., Nobuhito Kashiwagi, G Teuber, et al.. (2005). Leucoytapheresis with Adacolumn® enhances HCV-specific proliferative responses in patients infected with hepatitis C virus genotype 1. Journal of Medical Virology. 77(2). 209–215. 7 indexed citations

16.

Teuber, G, M. Pascu, Thomas Berg, et al.. (2003). Randomized, controlled trial with IFN-α combined with ribavirin with and without amantadine sulphate in non-responders with chronic hepatitis C. Journal of Hepatology. 39(4). 606–613. 34 indexed citations

17.

Konrad, Thomas R., Stefan Zeuzem, Gianna Toffolo, et al.. (2000). Severity of HCV-Induced Liver Damage Alters Glucose Homeostasis in Noncirrhotic Patients with Chronic HCV Infection. Digestion. 62(1). 52–59. 48 indexed citations

18.

Lee, Jung-Hun, G Teuber, Michael Wagner, W. Kurt Roth, & Stefan Zeuzem. (2000). Antiviral effect of human recombinant interleukin-12 in patients infected with hepatitis C virus. Journal of Medical Virology. 60(3). 264–268. 11 indexed citations

19.

Sarrazin, Christoph, Thomas Berg, Jung-Hun Lee, et al.. (1999). Improved correlation between multiple mutations within the NS5A region and virological response in European patients chronically infected with hepatitis C virus type 1b undergoing combination therapy. Journal of Hepatology. 30(6). 1004–1013. 63 indexed citations

20.

Teuber, G, H. P. Dienes, K. H. Meyer zum Büschenfelde, & G Gerken. (1996). Long-term follow-up of patients with chronic hepatitis B after interferon treatment.. PubMed. 34(4). 230–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact